Find the Right Market Report

Search thousands of industry reports, market insights, and research studies in one place.

Not sure where to start? Try one of these:
Explore healthcare market intelligence and industry insights
Towards Healthcare

China Central Lab Corporate Milestones

Date : 02 June 2026

Latest Updates of Companies in the China Central Lab Market

China Central Lab Market Companies are WuXi AppTec, KingMylab, Tigermed, Pharmaron, JOINN Laboratories, Medicilon, SDM CRO, ChemPartner, Frontage Laboratories, KingMed Diagnostics

Company Headquarters Offerings Market Focus
WuXi AppTec Shanghai Central lab testing, genomics, biomarker analysis Global clinical trials
KingMylab Guangzhou Central laboratory services, bioanalysis, specimen management Oncology and biologics
Tigermed Hangzhou Central lab operations, clinical data management Multicenter studies
Pharmaron Beijing Laboratory testing, translational medicine Drug development
JOINN Laboratories Beijing Bioanalytical and toxicology testing Preclinical research
Medicilon Shanghai Biomarker assays, bioanalysis Early-stage R&D
SDM CRO Beijing Laboratory testing, biomarker services Vaccines and biologics
ChemPartner Shanghai Central lab and analytical services Pharma outsourcing
Frontage Laboratories Shanghai Bioanalytical and central lab services Clinical development
KingMed Diagnostics Guangzhou Clinical diagnostics, specimen logistics Hospital and CRO support

Recent Developments in the China Central Lab Market

  • In March 2026, Frontage Laboratories, Inc, a leading global CRO/CDMO, today announce    d the completion of the acquisition of Teddy Clinical Research Laboratory, Ltd., a leading clinical research laboratory service provider in China.
  • In March 2026, LabConnect, a premier provider of technology-focused central lab services and trial support, officially opened a new facility in Wuxi, China. This expansion enhances global clinical trial capabilities by offering integrated testing, sample tracking, and custom kit preparation.

Market Growth

The China central lab market size was estimated at USD 452.07 million in 2025 and is predicted to increase from USD 506.89 million in 2026 to approximately USD 1287.16 million by 2035, expanding at a CAGR of 10.91% from 2026 to 2035.

China Central Lab Market Size is USD 506.89 Million in 2026.

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.

Talk to an Analyst Contact Sales